Beta Bionics (BBNX) Change in Accured Expenses (2024 - 2026)

Beta Bionics has disclosed Change in Accured Expenses across 3 years of filings, most recently posting -$222000.0 for Q2 2026.

• In Q2 2026, Change in Accured Expenses fell 108.15% year-over-year to -$222000.0; the TTM figure through Jun 2026 stood at $4.5 million (up 104.37% YoY), while the FY2025 annual figure was $7.4 million, up 8.57% from the prior year.
• Change in Accured Expenses came in at -$222000.0 for Q2 2026 at Beta Bionics, up from -$5.2 million in the prior quarter.
• In the past five years, Change in Accured Expenses ranged from a high of $5.9 million in Q4 2025 to a low of -$5.3 million in Q1 2025.
• Average Change in Accured Expenses over 3 years is $882300.0, with a median of $1.8 million recorded in 2024.
• The largest YoY upside for Change in Accured Expenses was 242.92% in 2025 against a maximum downside of 2182.68% in 2025.
• Over 3 years, Change in Accured Expenses stood at $3.6 million in 2024, then jumped by 64.16% to $5.9 million in 2025, then slumped by 103.79% to -$222000.0 in 2026.
• Per Business Quant data, the three most recent Change in Accured Expenses figures were -$222000.0 in Q2 2026, -$5.2 million in Q1 2026, and $5.9 million in Q4 2025.